• 1
    Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bates Z, Waggoner JG, Kaplowitz N, et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States. N Engl J Med 1987; 316:966970.
  • 2
    Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292:771774. MEDLINE
  • 3
    Beasley RP, Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 1983; 147:185190. MEDLINE
  • 4
    Lok AS, Lai CL. Acute exacerbations in chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. J Hepatol 1990; 10:2344. MEDLINE
  • 5
    Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 1991; 100:182188. MEDLINE
  • 6
    Penna A, Chisari FV, Bertoletti A, Missale G, Fowler P, Guiberti T, Fiaccadori F, et al. Cytotoxic T lymphocyte recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991; 174:15651570. MEDLINE
  • 7
    Ferrari C, Penna A, Guiberti T, Tong MJ, Ribera E, Fiaccadori F, Chisari FV. Intrahepatic nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol 1987; 139:20502058. MEDLINE
  • 8
    Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, Moss B, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995; 181:10471058. MEDLINE
  • 9
    Bertoletti A, Ferrari C, Ficcadori F, Penna A, Margolskee R, Schlicht HJ, Fowler P, et al. HLA class I–restricted human cytotoxic T cells recognized endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A 1991; 88:1044510449. MEDLINE
  • 10
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello R, et al. HLA-A2 restricted cytotoxic T lymphocytes response to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993; 150:46594671. MEDLINE
  • 11
    Rehermann B, Lau D, Hoofnagle JH, Chisari FV. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 1996; 97:16551665. MEDLINE
  • 12
    Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, Scognamiglio P, et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998; 102:968975. MEDLINE
  • 13
    Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A 1994; 91:37643768. MEDLINE
  • 14
    Vitiello A, Ishioka G, Grey HM, Rose R, Farness P, LaFond R, Yuan L, et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. J Clin Invest 1995; 95:341349. MEDLINE
  • 15
    Celis E, Tsai V, Crimi C, DeMars R, Wentworth PA, Chesnut RW, Grey HM, et al. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci U S A 1994; 91:21052109. MEDLINE
  • 16
    Livingston BD, Crimi C, Grey H, Ishioka G, Chisari FV, Fikes J, Grey H, et al. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J Immunol 1997; 13831392.
  • 17
    Lau GK, Lok AS, Liang RH, Lai CL, Chiu EK, Lau YL, Lam SK. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Hepatology 1997; 25:14971501. MEDLINE
  • 18
    Livingston BD, Alexander J, Crimi C, Celis E, Daly K, Guidotti LG, Chisari FV, et al. Altered helper T lymphocytes function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. J Immunol 1999; 162:30883095. MEDLINE
  • 19
    Artillo S, Pastore G, Alberti A, Milella M, Santantonio T, Fattovich G, Guistina G, et al. Double-blind randomized trial of interleukin-2 treatment of chronic hepatitis B. J Med Virol 1998; 54:167172. MEDLINE
  • 20
    Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Del Guercio MF, Oseroff C, et al. Utilization of MHC class I transgenic mice for the development of minigene vaccines encoding multiple HLA-restricted CTL epitopes. J Immunol 1999; 162:39153925. MEDLINE